Optimizing infant HIV diagnosis with additional screening at immunization clinics in three sub‐Saharan African settings: a cost‐effectiveness analysis
L. H. DUNNING(University of Cape Town), Andrea Ciaranello(Harvard University), Martina Penazzato(World Health Organization), Paul Revill(University of York), Angela Mushavi(Ministry of Health and Child Welfare), Lara Vojnov(Clinton Health Access Initiative), Caitlin M. Dugdale(Harvard University), Intira Jeannie Collins(University College London), Elaine J. Abrams(Columbia University), Marie‐Louise Newell(University College London), Djøra I. Soeteman(Massachusetts General Hospital), Patricia Fassinou Ekouévi(Elizabeth Glaser Pediatric AIDS Foundation), Landon Myer(University of Cape Town), Simone C. Frank(Massachusetts General Hospital), Meg Doherty(World Health Organization), Kenneth A. Freedberg(Massachusetts General Hospital), Andrew Phillips(University College London), Milton C. Weinstein, Aditya R Gandhi(Massachusetts General Hospital)
Cited by 10
Related Papers
National and regional estimates of term and preterm babies born small for gestational age in 138 low-income and middle-income countries in 2010
|The Lancet Global Health|2013|858
The Cost Effectiveness of Combination Antiretroviral Therapy for HIV Disease
|New England Journal of Medicine|2001|519
Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
|Diabetes Care|2008|477